Abstract
In respiratory physiology the nose is an organ with a great importance that supposes 50% of the resistances to the airflow, and its pathology requires, in many occasions, of a multidisciplinary work. In recent years it has been demonstrated that bronchopulmonary pathologies are usually associated with nasosinusal pathology, thus creating the concept of rhinobronchitis and “one airway, one disease.” There are few studies that correlate bronchiectasis (BQs) and CRS. The most frequent symptoms of CRS in patients with BQs are anterior rhinorrhea, posterior rhinorrhea, and nasal obstruction. Seventy-seven percent of patients with BQs had CRS, while 25% had mild to moderate nasal polyposis. Patients with nasal polyposis were diagnosed with BQs more than 10 years earlier than patients without nasal pathology.
Guilemany et al. observed that patients with BQs and CRS, with or without polyps, had a greater pulmonary involvement on CT compared with those without CRS. This finding suggests that CRS is a marker of activity in BQs patients.
Guilemany et al. were the first to assess the effect on general quality of life (QoL) in patients with BQs and CSR using the SF-36 test showing that in all domains of the test, patients with BQs and CSR were worse than the general population. Patients with mild-moderate nasal polyposis had increased nasal obstruction and increased loss of smell but did not present worsen quality of life.
The SNOT-20 test, which evaluates the patient-reported measure of outcome in sinonasal disorders, showed that patients with BQs and CSR had a higher score in the test than those with BQs without CSR. No difference was observed between CRS with or without PN, but it should be taken into account that this test does not analyze nasal obstruction or olfaction, factors that can be determinant in QoL.
CRS without or with nasal polyps is the main cause of a partial or total loss of smell in a patient with bronchiectasis. Thus, an alert symptom like “the loss of smell” may help respiratory physicians to refer the patients to an ENT specialist for further diagnose and management of CRS.
The high prevalence of nasosinusal pathology in patients with BQ leads us to conclusion that an otolaryngologist should rule out CRS in patients with BQs, and, conversely, in patients with CRS, diseases such as asthma, COPD and BQ should be studied.
References
Simons FE. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol. 1999;104:534–40.
Bachert C, Vignola AM, Gevaert P, Leynaert B, Van Cauwenber-Ge P, Bousquet J. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin Am. 2004;24:19–43.
Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108:S147–334.
Vignola A, Bousquet J. Rhinitis and asthma: a continuum disease? Clin Exp Allergy. 2001;31:674–7.
Gaga M, Vignola AM, Chánez P. Upper and lower airways: similarities and differences. In: Wallaërt B, Chánez P, Godard P, editors. The nose and lung diseases, European Respiratory Society monograph, vol. 6; 2001. p. 10–5.
Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1989;11(1):520–4.
Martínez-Hernandez A, Amenta PS. The basement membrane in pathology. Lab Investig. 1983;48:656–77.
Chánez P, Vignola AM, Vic P, Guddo F, Bonsignore G, Godard P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med. 1999;159:588–95.
Rutland J, Griffin WM, Cole PJ. Human ciliary beat frequency in epithelium from intrathoracic and extrathoracic airways. Am Rev. Respir Dis. 1982;125:100–5.
Tint D, Kubala S, Toskala E. Risk factors and comorbidities in chronic Rhinosinusitis. Curr Allergy Asthma Rep. 2016 Feb;16(2):16.
Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps. Rhinology. 2007;2007(20):1–136.
Carney AS, Tan LW, Adams D, Varelias A, Ooi EH, Wormald PJ. Th2 immunological inflammation in allergic fungal sinusitis, nonallergic eosinophilic fungal sinusitis, and chronic rhinosinusitis. Am J Rhinol. 2006;20:145–9.
Hashiba M, Baba S. Efficacy of long-term administration of clarithromycin in the treatment of chronic sinusitis. Acta Otolaryngol Suppl. 1996;525:73–8.
Mullol J, López E, Roca-Ferrer J, Xaubet A, Pujols L, Fernández-Morata JC, Fabra JM, Picado C. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium. Clin Exp Allergy. 1997;27:1432–41.
El Nagar M, Kale S, Aldren C, Martin F. Effect of beconase nasal spray on olfactory function in post-nasal polypectomy patients: a prospective controlled trial. J Larungol Otol. 1995;109:941–4.
Guilemany JM, Angrill J, Alobid I, Centellas S, Pujols L, Bartra J, Bernal-Sprekelsen M, Valero A, Picado C, Mullol J. United airway again: high prevalence of rhinosinusitis and nasal polyps in bronchiectasis. Allergy. 2009;64:790–7.
Smith IE, Jurriaans E, Diederich S, Ali N, Shneerson JM, Flower CD. Chronic sputum production: correlations between clinical features and finding on high resolution computed tomographic scanning of the chest. Thorax. 1996;51:914–8.
Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med. 2007;101(6):1163–70.
Hens G, Vanaudenaerde BM, Bullens DM, Piessens M, Decramer M, Dupont LJ, Ceuppens JL, Hellings PW. Sinonasal pathology in nonallergic asthma and COPD: “united airway disease” beyond the scope of allergy. Allergy. 2008;63:261–7.
Lindberg S, Cervin A, Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol 1977;117:113–117.
Pujols L, Mullol J, Picado C. Alpha and beta glucocorticoid receptors: relevance in airway diseases. Curr Allergy Asthma Rep. 2007;7:93–9.
Toppila-Salami SK, Myller JP, Torkkeli TV, Muhonen JV, Renkonen JA, Rautiainen ME, Renkonen RL. Endothelial L-selectin ligands in sinus mucosa during chronic maxillary rhinosinusitis. Am J Respir Crit Care Med. 2005;171:1350–7.
Boone M, et al. Diagnostic accuracy of nitric oxide measurements to detect primary ciliary dyskinesia. Eur J Clin Investig. 2014;44(5):477–85.
Guilemany JM, Alobid I, Angrill J, Ballesteros F, Bernal-Sprekelsen M, Picado C, Mullol J. The impact of bronchiectasis associated to sinonasal disease on quality of life. Respir Med. 2006;100:1997–2003.
Guilemany JM, Angrill J, Alobid I, Centellas S, Prades E, Roca J, Pujols L, Bernal-Sprekelsen M, Picado C, Mullol J. United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient’s quality of life. Allergy. 2009;64:1524–9.
Rosell A, Monso E, Soler N, Torres F, Angrill J, Riise G, et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med. 2005;165:891–7.
Osborne ML, Vollmer WM, Linton KL, Buist AS. Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med. 1998;157:123–8.
Ragab S, Scadding GK, Lund V, Saleh H. Treatment of chronic rhinosinusitis and its effects on asthma. Eur Respir J. 2006;28:68–74.
Guilemany JM, Mariño-Sánchez FS, Angrill J, Alobid I, Centellas S, Pujols L, Berenguer J, Bernal-Sprekelsen M, Picado C, Mullol J. The importance of smell in patients with bronchiectasis. Respir Med. 2011 Jan;105(1):44–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Nogués Sabaté, A., Guilemany Toste, J.M. (2018). Chronic Rhinosinusitis and Bronchiectasis. In: Chalmers, J., Polverino, E., Aliberti, S. (eds) Bronchiectasis. Springer, Cham. https://doi.org/10.1007/978-3-319-61452-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-61452-6_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61451-9
Online ISBN: 978-3-319-61452-6
eBook Packages: MedicineMedicine (R0)